Fig. 1From: Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanomaSchematic overview of nivolumab-treated patients with malignant melanomaThe inclusion criteria and numbers of each group are described. irAE, immune-related adverse event. *Patients with current active thyroid dysfunction and without evaluation of thyroid function were excludedBack to article page